Max Tsai
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Surgery 12
- Intraperitoneal and Appendiceal Malignancies 5
-
- Receptor Mechanisms and Signaling 8
- Phosphodiesterase function and regulation 7
- Co-authors
- Jessie L.‐S. Au (7 shared papers)Ze Lu (7 shared papers)Teng‐Kuang Yeh (2 shared papers)M. Guillaume Wientjes (6 shared papers)M. Guill Wientjes (1 shared paper)Darren Wilbraham (8 shared papers)Jie Wang (1 shared paper)Dan Lü (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Psychopharmacology (2 papers)European Journal of Clinical Pharmacology (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Max Tsai
28 papers receiving 759 citations
Peers
Comparison fields: 5 of 82
- Biomaterials 227
- Pharmaceutical Science 72
- Psychiatry and Mental health 116
- Reproductive Medicine 54
- Pharmacology 99
Countries citing papers authored by Max Tsai
This map shows the geographic impact of Max Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Tsai more than expected).
Fields of papers citing papers by Max Tsai
This network shows the impact of papers produced by Max Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Tsai. The network helps show where Max Tsai may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 189 | |
| 2 | 2007 | 109 | |
| 3 | 2008 | 83 | |
| 4 | 2019 | 49 | |
| 5 | 2020 | 45 | |
| 6 | 2018 | 41 | |
| 7 | 2013 | 33 | |
| 8 | 2014 | 24 | |
| 9 | 2016 | 22 | |
| 10 | 2019 | 22 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 17 | |
| 13 | 2016 | 16 | |
| 14 | 2020 | 16 | |
| 15 | 2017 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2016 | 13 | |
| 18 | 2018 | 11 | |
| 19 | Evaluation of safety and pharmacokinetics of a fully human IGF-1 receptor antibody, SCH 717454, in healthy volunteers | 2007 | 8 |
| 20 | 2012 | 8 |
About Max Tsai
Max Tsai is a scholar working on Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health, having authored 29 papers that have together received 784 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Phosphodiesterase function and regulation (7 papers), Blood Pressure and Hypertension Studies (6 papers), Intraperitoneal and Appendiceal Malignancies (5 papers), Migraine and Headache Studies (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Biomaterials (227 citations), Pharmaceutical Science (72 citations), Psychiatry and Mental health (116 citations), Reproductive Medicine (54 citations) and Pharmacology (99 citations). Max Tsai has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Jessie L.‐S. Au, Ze Lu, Teng‐Kuang Yeh, M. Guillaume Wientjes, M. Guill Wientjes, Darren Wilbraham, Jie Wang, Jie Wang, Dan Lü and Tolga Uz. Their work appears in journals such as The Journal of Clinical Pharmacology, Psychopharmacology, European Journal of Clinical Pharmacology, Molecular Cancer Therapeutics and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.